An 80-year-old woman presented to the emergency department due to dyspnea for 3 weeks. She was admitted to the hospital with a diagnosis of massive pleural effusion. Thoracentesis revealed a transudative effusion. Adenosine deaminase level in the fluid was 12 U/L (normal range, 0-40 U/L), and erythrocyte sedimentation rate was 94 mm/h. Control chest X-ray examination revealed cardiomegaly (Fig. 1) . Transthoracic echocardiography revealed hyperechogenic pericardial effusion (Fig. 2 , Panels A and B; Videos 1 and 2). Inferior vena cava plethora with blunted respiratory response was present (Fig. 2, Panel C) . Significant respiratory variation in mitral inflow was observed (Fig. 2, Panel D) . PET/CT revealed 20 mm of pericardial effusion and increased FDG uptake in the pericardium with an SUVmax
E and F). Based on these findings, tuberculous effusive constrictive pericarditis was the preliminary diagnosis. The patient was referred to a pulmonologist, and anti-tuberculosis therapy was initiated. The patient was prescribed isoniazid, rifampicin, pyrazinamide, and ethambutol for 2 months and isoniazid and rifampicin for additional 7 months. Colchicine was started during the third month and continued till the end of anti-tuberculosis therapy. Ibuprofen was prescribed during the third month and continued for 1 month. Symptoms of the patient improved, and pericardial effusion resolved during follow-up (Fig. 2 , Panels G and H; Videos 3 and 4). Inferior vena cava plethora and mitral inflow were normalized (Fig. 2 , Panels I and J). PET/CT confirmed the resolution of pericardial effusion and normalized FDG uptake in the pericardium. No complication was observed at 1 year of follow-up.
Effusive constrictive pericarditis is usually associated with tuberculosis. Medical therapy including anti-tuberculosis and anti-inflammatory agents should be attempted before performing a high risk surgery such as pericardiectomy. 
